These findings support the continued use of GLP-1 RAs in clinical practice, but further research is needed to fully understand their long-term oncological safety, particularly in relation to non-gastrointestinal cancers and rare malignancies such as pancreatic cancer
Myo-Inositol Improves insulin sensitivity Restores hormonal balance (especially in PCOS) Supports ovulation and egg quality Reduces androgen levels in women 3
Recommendations for athletes on GLP-1s Still, experts in the field believe there is enough concern not just to warrant further research but to advise athletes to take steps to avoid this loss in lean body mass as much as possible
Later, when asked to confirm this figure, the company declined to do so
"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed
This may lead to impairment of cellular signaling mechanisms and accumulation of misfolded proteins causing proteotoxicity associated with cardiac dysfunction (136143)